Etelcalcetide is a synthetic peptide belonging to the calcimimetic class, primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease who are undergoing hemodialysis.… Read more
Etelcalcetide is a synthetic peptide belonging to the calcimimetic class, primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease who are undergoing hemodialysis. By activating calcium-sensing receptors, this compound effectively reduces parathyroid hormone secretion. This category provides access to high-quality reference standards, including the active pharmaceutical ingredient and various related compounds necessary for comprehensive laboratory analysis. Scientists rely on these materials, which encompass critical impurities such as des-acetyl forms, dimers, and trifluoroacetate salts, to support rigorous impurity profiling, method validation, and quality control procedures. The availability of these characterized standards ensures that analytical testing remains consistent and precise throughout the drug development and manufacturing lifecycle, facilitating the accurate identification and quantification of impurities in complex pharmaceutical formulations.